Page 1 of Clinical Trials for Rheumatoid arthritis with inadequate response to 1 anti-TNF, 32 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis
Last Updated: June 25, 2010
Condition(s): Rheumatoid Arthritis
2
Active, not recruiting
AB1010 in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid Arthritis
Last Updated: June 3, 2009
Condition(s): Rheumatoid Arthritis
3
Recruiting
Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 1 Year of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents
Last Updated: May 4, 2012
Condition(s): Rheumatoid Arthritis
4
Recruiting
A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.
Last Updated: January 17, 2012
Condition(s): Rheumatoid Arthritis
5
Completed
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.
Last Updated: October 15, 2009
Condition(s): Rheumatoid Arthritis
6
Active, not recruiting
A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to DMARD and/or Anti-TNF Therapy.
Last Updated: May 21, 2012
Condition(s): Rheumatoid Arthritis
7
Completed
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents.
Last Updated: May 21, 2012
Condition(s): Rheumatoid Arthritis
8
Active, not recruiting
An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-TNF Therapy
Last Updated: March 16, 2012
Condition(s): Rheumatoid Arthritis
9
Active, not recruiting
A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.
Last Updated: March 16, 2012
Condition(s): Rheumatoid Arthritis
10
Completed
Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis
Last Updated: August 11, 2009
Condition(s): Rheumatoid Arthritis
11
Completed
Study of Atacicept in Anti-TNFα-naïve Patients With Moderate to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Last Updated: August 23, 2011
Condition(s): Rheumatoid Arthritis
12
Completed
A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET)
Last Updated: January 7, 2011
Condition(s): Rheumatoid Arthritis
13
Terminated
A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)
Last Updated: June 25, 2010
Condition(s): Rheumatoid Arthritis
14
Completed
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
Last Updated: February 23, 2012
Condition(s): Rheumatoid Arthritis
15
Recruiting
Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents
Last Updated: May 4, 2012
Condition(s): Rheumatoid Arthritis
16
Completed
An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.
Last Updated: December 7, 2011
Condition(s): Rheumatoid Arthritis
17
Completed
SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy
Last Updated: February 15, 2012
Condition(s): Rheumatoid Arthritis
18
Completed
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Last Updated: June 10, 2010
Condition(s): Rheumatoid Arthritis
19
Recruiting
An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biologic DMARD and/or Anti-TNF Therapy
Last Updated: May 21, 2012
Condition(s): Rheumatoid Arthritis
20
Recruiting
A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)
Last Updated: May 22, 2012
Condition(s): Rheumatoid Arthritis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Rheumatoid+arthritis+with+inadequate+response+to+1+anti-TNF

Page 1 of Clinical Trials for Rheumatoid arthritis with inadequate response to 1 anti-TNF, 32 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About